View Printer-Friendly PDF

A Drug Development & Outsourcing Profile

AbCellera

2215 Yukon St.
Vancouver BC  V5Y 0A1
Canada

  • Tel: 604-559-9005
  • CEO: Carl L. Hansen, PhD
  • Mktg:
  • R&D:
  • Licng:
  • Est: 2012 - Private
  • Rev: $ M
  • Staff: 100–500
  • Antibodies
  • Therapeutics-Human
  • Therapeutics-Protein

AbCellera is a privately held biotechnology company with a drug discovery platform that searches and analyzes natural immune systems to find antibodies used to prevent and treat disease. AbCellera’s technology combines high-throughput microfluidics, AI and genomics, and provides in-house access to transgenic mouse and bispecific platforms to identify first-in-class drugs and reduce the time of bringing treatments to the clinic. AbCellera's partners include leading biotechs and top 10 biopharmaceutical companies.

Mfg:    Labs:

0.0253